Cromos Pharma

Cromos Pharma Cromos Pharma is an international research organization (CRO) specializing in clinical trials. Find out more by visiting www.cromospharma.com.

Established in 2004, Cromos Pharma provides tailored and effective clinical trial services to support the development of drugs that transform healthcare. It is an international CRO with over 15 years' experience in offering fully integrated services and delivering all aspects of clinical trials in all clinical phases and a range of therapeutic areas. Cromos Pharma delivers rapid recruitment and ex

cellent patient retention as well as expert study design and management. Cromos Pharma has strong regional experience in Central and Eastern Europe. Its US base is in Portland, Oregon with additional operations in South Florida and its European HQ is situated in Dublin, Ireland.

AI is no longer viewed simply as a tool for operational efficiency in clinical trials.The FDA is increasingly positionin...
05/28/2026

AI is no longer viewed simply as a tool for operational efficiency in clinical trials.

The FDA is increasingly positioning AI as part of the clinical development infrastructure itself, with growing focus on governance, oversight, transparency, and regulatory trust.
In this article, we explore what the FDA’s recent initiatives could mean for the future of clinical research and why the industry may be entering a new phase of AI adoption.

Read more: https://cromospharma.com/fda-ai-and-the-future-of-clinical-trials/

Poland is no longer just a cost-driven clinical research destination.With strong oncology patient access, experienced in...
05/27/2026

Poland is no longer just a cost-driven clinical research destination.

With strong oncology patient access, experienced investigators, growing infrastructure, and increasing operational maturity, the country is becoming a strategic market for European oncology trials.

In this article, Magda Klosowska, Regional Clinical Manager for Europe at Cromos Pharma, shares why sponsors should rethink Poland’s role in oncology clinical development.

Read more: https://cromospharma.com/cro-in-poland-why-poland-is-becoming-a-core-country-for-oncology-clinical-trials-in-europe/

05/26/2026

We’re pleased to share that Nicole Brenna, US Business Development Director at Cromos Pharma, will be attending the BIO International Convention 2026, taking place June 22–25 in San Diego, CA.

BIO is one of the leading global biotechnology events, bringing together professionals across biotech, pharma, clinical research, and healthcare innovation. The convention offers valuable opportunities for networking, partnership development, and discussions on the future of life sciences.

Nicole is looking forward to meeting with industry colleagues and discussing how Cromos Pharma supports global clinical development programs across a wide range of therapeutic areas.

If you will be attending BIO 2026 and would like to connect, please contact us at [email protected]

05/22/2026

As Memorial Day weekend begins, Cromos Pharma takes a moment to honor and remember the brave men and women who gave their lives in service to their country.

We sincerely thank them for their sacrifice, courage, and dedication. Wishing everyone a safe and meaningful holiday weekend.

05/21/2026

We’re pleased to share that Vlad Bogin, MD, FACP will be attending the 2026 ASCO Annual Meeting, taking place May 29 – June 2, in Chicago, IL.

ASCO remains one of the leading global oncology events, bringing together experts across clinical research and healthcare to discuss the latest scientific advances, innovative therapies, and the future of cancer care. The meeting also provides a valuable opportunity to exchange insights on oncology clinical development and evolving clinical trial strategies.

Vlad is looking forward to meeting with industry colleagues and discussing how Cromos Pharma can support oncology clinical development programs worldwide.

If you will be attending ASCO and would like to connect, please contact us at [email protected]

On World Clinical Trials Day, the conversation is no longer only about innovation.As clinical trials become more complex...
05/20/2026

On World Clinical Trials Day, the conversation is no longer only about innovation.

As clinical trials become more complex across operations, technology, patient recruitment, and site management, the industry is facing a new challenge: not just developing therapies, but delivering trials efficiently at scale.

In our latest article, we explore the key trends shaping clinical research in 2026. Read more: https://cromospharma.com/world-clinical-trials-day-clinical-research-is-not-where-it-used-to-be/?preview_id=11753&preview_nonce=c21d76b9e3&_thumbnail_id=11754&preview=true

The recent US–UK pharmaceutical agreement may be about far more than drug pricing.Pharma is increasingly becoming part o...
05/12/2026

The recent US–UK pharmaceutical agreement may be about far more than drug pricing.

Pharma is increasingly becoming part of trade strategy, industrial policy, and geopolitical competition. As global powers compete for innovation, investment, and manufacturing leadership, the rules shaping the industry may be changing faster than many realize.

Read more:https://cromospharma.com/the-us-uk-pharma-deal-is-bigger-than-it-looks/

In the latest edition of Cromos Pharma’s Newsletter, we highlight key developments shaping clinical research in 2026:– F...
05/07/2026

In the latest edition of Cromos Pharma’s Newsletter, we highlight key developments shaping clinical research in 2026:

– FDA Transparency Pressure: More than 2,200 sponsors were flagged over missing trial results, highlighting growing scrutiny around data reporting and clinical transparency.
– Rare Disease Innovation: EMA recommended approval of plozasiran, a first in class siRNA therapy for familial chylomicronaemia syndrome with significant reductions in triglycerides and pancreatitis risk.
– A Potential Breakthrough in Pancreatic Cancer: Daraxonrasib Phase III data demonstrated one of the most meaningful survival advances seen in pancreatic cancer in decades.

Read the full newsletter: https://cromospharma.com/clinical-research-focus-52nd-edition/

Address

US Bancorp Tower, 111 S. W. Fifth Avenue, Suite 3150
Portland, OR
97204

Telephone

+15034443463

Website

Alerts

Be the first to know and let us send you an email when Cromos Pharma posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share